Primary Hyperparathyroidism

Also known as: Hyperparathyroidism primary / Hyperparathyroidism, Primary / Primary Hyperparathyroidisms / Hyperplasia of parathyroid

DrugDrug NameDrug Description
DB01012CinacalcetA calcium sensing receptor agonist used to treat secondary hyperparathyroidism in chronic kidney disease and hypercalcemia in parathyroid carcinoma.
DrugDrug NamePhaseStatusCount
DB00158Folic acid1Completed1
DB01373Calcium2Recruiting1
DB01012Cinacalcet2Completed4
DB11094Vitamin D2Recruiting1
DB00594Amiloride2 / 3Recruiting1
DB00169Cholecalciferol2 / 3Completed1
DB01012Cinacalcet2 / 3Recruiting1
DB00700Eplerenone2 / 3Recruiting1
DB11094Vitamin D2 / 3Completed1
DB01012Cinacalcet3Completed3
DB06643Denosumab3Completed1
DB12388Evocalcet3Completed1
DB00630Alendronic acid4Completed1
DB00169Cholecalciferol4Completed1
DB01012Cinacalcet4Completed1
DB06643Denosumab4Completed1
DB06643Denosumab4Recruiting1
DB00017Salmon Calcitonin4Recruiting1
DB09267Strontium ranelate4Completed1
DB11094Vitamin D4Completed1
DB00399Zoledronic acid4Recruiting1
DB00630Alendronic acidNot AvailableCompleted1
DB06724Calcium carbonateNot AvailableCompleted1
DB00169CholecalciferolNot AvailableCompleted1
DB01012CinacalcetNot AvailableActive Not Recruiting1
DB01012CinacalcetNot AvailableCompleted1